P16/INK4A up-regulation mediated by SIX6 defines retinal ganglion cell pathogenesis in glaucoma
Glaucoma, a blinding neurodegenerative disease, whose risk factors include elevated intraocular pressure (IOP), age and genetics, is characterized by accelerated and progressive retinal ganglion cell (RGC) death. Despite decades of research, the mechanism of RGC death in glaucoma is still unknown. H...
Gespeichert in:
Veröffentlicht in: | Molecular cell 2015-09, Vol.59 (6), p.931-940 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Glaucoma, a blinding neurodegenerative disease, whose risk factors include elevated intraocular pressure (IOP), age and genetics, is characterized by accelerated and progressive retinal ganglion cell (RGC) death. Despite decades of research, the mechanism of RGC death in glaucoma is still unknown. Here, we demonstrate that the genetic effect of the
SIX6
risk-variant (rs33912345, His141Asn) is enhanced by another major POAG risk gene
P16/INK4A
(cyclin-dependent kinase inhibitor 2A). We further show that the upregulation of homozygous
SIX6
risk alleles (CC) leads to an increase in
P16/INK4A
expression with a subsequent cellular senescence, as evidenced in a mouse model of elevated IOP and in human POAG eyes. Our data indicate that
SIX6
and/or IOP promotes POAG by directly increasing
P16/INK4A
expression, leading to RGC senescence in adult human retinas. Our study provides important insights linking genetic susceptibility to the underlying mechanism of RGC death and provides a unified theory of glaucoma pathogenesis. |
---|---|
ISSN: | 1097-2765 1097-4164 |
DOI: | 10.1016/j.molcel.2015.07.027 |